Article

News

ARVO 2024: Researchers detail novel glaucoma shunt

Author(s):

In a presentation at the Association for Research in Vision and Ophthalmology 2024 annual meeting in Seattle, researchers detailed a novel shunt, which could potentially improve postoperative IOP control and lower the risk of vision-threatening issues.

(Image credit: Adobe Stock)

(Image credit: Adobe Stock)

In a study presented this week at the Association for Research in Vision and Ophthalmology (ARVO) 2024 annual meeting in Seattle, a team of researchers introduced a new type of shunt for treating glaucoma that can be adjusted after surgery to control how much fluid flows out of the eye.

According to a news release, this novel shunt could potentially improve postoperative IOP control and lower the risk of vision-threatening issues.1

Ariana Levin, MD, from New York University, along with researchers from Myra Vision in California and the John A. Moran Eye Center in Utah, at ARVO presented a novel shunt that can be opened or closed with a laser.

Levin noted in the news release that researchers developed a novel titratable aqueous shunt for glaucoma therapy designed to allow physicians to increase or decrease the flow of aqueous fluid through the shunt in a slit lamp-based laser procedure.1

“The potential to control aqueous fluid in the postoperative period may allow physicians to personalize care for every patient and potentially improve the safety and efficacy of glaucoma surgery,” she said in the news release.

Reference
The Association for Research in Vision and Ophthalmology-. www.arvo.org. Accessed May 6, 2024. https://www.arvo.org/About/press-room/press-room/novel-glaucoma-shunt-breakthrough/

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.